Baseline Anti-Ns4a Antibodies in Combination With on-Treatment Quantitative HCV-Rna Reliably Identifies Non Responders to Peginterferon-Ribavirin Combination Therapy After 4 Weeks of Treatment
Journal article published in 2008 by
Hans Orlent,
Isabelle Desombere,
Bettina E. Hansen 
,
Hans Van Vlierberghe,
Bart Haagmans,
Robert J. de Knegt,
Solko W. Schalm,
Geert Leroux-Roels,
Harry L. Janssen
,
Hans Van Vlierberghe,
Bart Haagmans,
Robert J. de Knegt,
Solko W. Schalm,
Geert Leroux-Roels,
Harry L. Janssen
